- Open Access
A bacteriocin gene cluster able to enhance plasmid maintenance in Lactococcus lactis
Microbial Cell Factories volume 13, Article number: 77 (2014)
Lactococcus lactis is widely used as a dairy starter and has been extensively studied. Based on the acquired knowledge on its physiology and metabolism, new applications have been envisaged and there is an increasing interest of using L. lactis as a cell factory. Plasmids constitute the main toolbox for L. lactis genetic engineering and most rely on antibiotic resistant markers for plasmid selection and maintenance. In this work, we have assessed the ability of the bacteriocin Lactococcin 972 (Lcn972) gene cluster to behave as a food-grade post-segregational killing system to stabilize recombinant plasmids in L. lactis in the absence of antibiotics. Lcn972 is a non-lantibiotic bacteriocin encoded by the 11-kbp plasmid pBL1 with a potent antimicrobial activity against Lactococcus.
Attempts to clone the full lcn972 operon with its own promoter (P972), the structural gene lcn972 and the immunity genes orf2-orf3 in the unstable plasmid pIL252 failed and only plasmids with a mutated promoter were recovered. Alternatively, cloning under other constitutive promoters was approached and achieved, but bacteriocin production levels were lower than those provided by pBL1. Segregational stability studies revealed that the recombinant plasmids that yielded high bacteriocin titers were maintained for at least 200 generations without antibiotic selection. In the case of expression vectors such as pTRL1, the Lcn972 gene cluster also contributed to plasmid maintenance without compromising the production of the fluorescent mCherry protein. Furthermore, unstable Lcn972 recombinant plasmids became integrated into the chromosome through the activity of insertion sequences, supporting the notion that Lcn972 does apply a strong selective pressure against susceptible cells. Despite of it, the Lcn972 gene cluster was not enough to avoid the use of antibiotics to select plasmid-bearing cells right after transformation.
Inserting the Lcn972 cluster into segregational unstable plasmids prevents their lost by segregation and probable could be applied as an alternative to the use of antibiotics to support safer and more sustainable biotechnological applications of genetically engineered L. lactis.
Lactococcus lactis is widely used as starter in the manufacture of cheese. It belongs to the diverse group of lactic acid bacteria which are characterized by the production of large quantities of lactic acid as a consequence of the fermentative metabolism of carbohydrates. Due to its main role in food fermentation, L. lactis has been extensively studied and has become a model lactic acid bacterium. The deep knowledge of L. lactis physiology along with the advent of high-throughput technologies (−omics) has paved the way for novel biotechnological applications of this species . Among them, it is worth mentioning several metabolic engineering strategies to re-route L. lactis metabolism to the production of metabolites of interest for both food and pharmaceutical industries. L. lactis has been engineered to produce commodity chemicals such as mannitol and 2,3-butanediol ex situ, i.e. as a cell factory or to produce vitamins in situ[2, 3]. L. lactis is also a suitable platform for the production of recombinant proteins [4, 5].
To address these challenges, several genetic tools have been devised that expand from replicative cloning plasmids to chromosomal integration strategies, (inducible-) gene expression platforms and synthetic promoters, among others [1, 5]. Plasmid-based approaches have already been exploited since 25 years ago and still comprise the main core of the L. lactis toolbox . Most of the lactococcal vectors rely on antibiotic resistance markers, namely erythromycin and chloramphenicol, which are needed for cloning and to stably maintain the plasmid during bacterial growth. However, in the context of biosafety, the use of antibiotics hinders large scale fermentations by increasing costs. Also, the risk of end-product contamination with the antibiotic is higher, and containment measurements to avoid spread of antibiotic resistance genes are required [7, 8]. Consequently, alternatives to antibiotic selection have been approached based on the complementation of auxotrophies and mutations in metabolic genes [9–12]. The use of antimicrobial peptides produced by bacteria (i.e. bacteriocins) as selecting agents and their cognate immunity genes as selectable marker genes have also been explored as food-grade cloning strategies. The nisin immunity gene nisI has been incorporated into plasmids that could be selected with nisin in Lactococci and Lactobacilli. Moreover, lacticin 481 and lacticin 3147 conjugative plasmids could be easily transferred in mating experiments by selection of transconjugants with the corresponding bacteriocin [14, 15]. These examples support the potential of bacteriocin-based approaches to develop food-grade genetic tools.
In this work, we have assessed the use of the Lcn972 gene cluster to improve the segregational stability of lactococcal plasmids without the aid of antibiotics. Lcn972 is a non-lantibiotic bacteriocin that selectively inhibits cell wall biosynthesis in Lactococci by binding to the cell wall precursor lipid II [16, 17]. Lcn972 is encoded by the theta-replicating 11 kbp-plasmid pBL1 [GenBank:AF242367.1]. The Lcn972 biosynthetic machinery comprises the structural gene lcn972 and two genes, orf2 and orf3 which could encode a putative ABC transporter involved in immunity [18, 19]. Shuttle E. coli-Lactococcus plasmids based on the pBL1 replicon revealed a high intrinsic instability, unusual for theta-replicating plasmids, and suggested that production of Lcn972 could be involved in postsegregational killing and, thereby, contribute to plasmid maintenance [18, 19]. On these premises, the segregational stability in the absence of antibiotics of different recombinant plasmids bearing the Lcn972 gene cluster has been evaluated.
Results and discussion
Cloning of the lcn972 cluster in the pIL252 replicon
Previous reports suggested a putative role of the Lcn972 gene cluster in the maintenance of the wild-type Lcn972-plasmid pBL1. First, attempts to cure pBL1 in the wild-type Lcn972 producer L. lactis IPLA972 failed . Secondly, the pBL1 replicon alone was segregationally unstable and was quickly lost in the absence of antibiotic selection. Moreover, pBL1 transfer to L. lactis by conjugative mobilization also failed due to the potent antimicrobial activity of donor cells on L. lactis recipient cells . Overall, these results supported the notion that the Lcn972 gene cluster might be involved in plasmid maintenance by post-segregational killing, i.e. eliminating those cells which have lost the plasmid during division due to the strong toxicity of the bacteriocin. To demonstrate if this was the case, we selected the plasmid pIL252, which has been shown to easily segregate in L. lactis[20, 21], to clone the Lcn972 gene cluster consisting of the structural gene lcn972 and the putative genes involved in immunity (orf2-orf3) (Figure 1).
Several attempts to clone the Lcn972 gene cluster with its own P972 promoter repeatedly failed and transformants were never recovered. Alternatively, the promoterless Lcn972 gene cluster was cloned in the vector pIL252 under the control of two available promoters: Pldh and Phyb (Figure 1). These promoters were chosen on the basis of their reported constitutive expression and high activity [22, 23]. The in vitro constructed recombinant pLDH and pHYB plasmids were easily introduced into L. lactis NZ9000 and preliminary testing confirmed the production of Lcn972.
Once the Lcn972 gene cluster was cloned in pIL252, attempts to introduce the original promoter P972 were approached and two other plasmids pOrf4 and pDorf4 were constructed (Figure 1). pOrf4 included orf4, an ORF of unknown function [GenBank:NP_862431], upstream of the Lcn972 gene cluster in pBL1. It is common that self-protection in bacteriocin producers rely on more than one immunity system as it is the case of several lantibiotics such as nisin and lacticin 3147 [24, 25] and the circular bacteriocin AS-48 . Therefore, we speculated that orf4 might be required to enhance survival of Lcn972 producing cells and, consequently, facilitate cloning of the whole Lcn972 gene cluster. However, when we tried to generate pOrf4, only one transformant was recovered. Sequencing of pOrf4 revealed the presence of a single nucleotide insertion (A, at position 3126 referred to pBL1 [GenBank:AF242367.1] coordinates) between the −35 (TTGACA) and −10 (TAAAAT) sequences of P972. Such mutation might interfere with transcription since the length of the spacer sequence between the −35 and the −10 sequences often determines promoter strength in L. lactis[27, 28]. However, L. lactis pOrf4 was still able to inhibit the growth of the indicator strain in the direct antagonism test (data not shown), indicating that Lcn972 was synthesized despite of the mutation. From pOrf4, another plasmid pDorf4 was generated by deleting the 5’ end of orf4 (see Figure 1) to check if there was any effect on bacteriocin titers or immunity in the absence of orf4 as described below.
Growth and bacteriocin production
Growth and bacteriocin production by all the pIL252 recombinant plasmids in L. lactis NZ9000 were assessed (Table 1). To compare their behaviour in terms of growth and bacteriocin production, L. lactis NZ9000 carrying pBL1 was used as a reference.
Growth kinetics of L. lactis carrying pLDH, pOrf4 or pBL1 showed similar growth rates, generation times and maximal OD (Table 1). L. lactis pDorf4 grew slightly slower but reached similar maximal OD as the others. On the contrary, cultures carrying the fusion of the Lcn972 cluster to the promoter Phyb had impaired growth and the growth rate was only 64% of that shown by the reference L. lactis with pBL1. Also, the maximal ODs reached at the end of the exponential phase were lower in L. latis pHYB cultures (Table 1).
Bacteriocin production was detected in the supernatant of all the cultures (Table 1) and was maximal at the end of the exponential phase, as previously described for pBL1 cultures  albeit bacteriocin titers encoded by pIL252 derivatives were lower than those provided by pBL1. On the other hand, Lcn972 activity provided by pHYB was 4 times lower than that by pLDH, likely reflecting the strength of each promoter (Table 1). Bacteriocin production by pOrf4 and pDorf4 plasmids was also lower than pBL1. Both recombinant plasmids reached similar titers regardless of the existence of orf4. Therefore, this gene does not seem to participate in Lcn972 biosynthesis or to provide additional immunity and the reason why the Lcn972 gene cluster with its own promoter could not be cloned in pIL252 remains unanswered.
Segregational stability of Lcn972-recombinant plasmids
In order to check if the Lcn972 gene cluster could enhance maintenance of the plasmids without antibiotic selection, L. lactis cultures carrying the recombinant plasmids were sub-cultured for 200 generations in GM17 and the fraction of erythromycin (Em)-resistant and Lcn972 producing colonies was calculated at time intervals (Figure 2). L. lactis pBL1 and pIL252 were also examined as references.
In agreement with previous reports, the plasmid pIL252 was quickly lost [20, 21], as judged by the loss of Em-resistance, whilst pBL1 remained stable and all the tested colony forming units (cfu) were able to produce Lcn972, confirmed by the presence of inhibition halos on L. lactis MG1614 plates (data not shown). The plasmid pLDH was also segregationally stable although 4.2% of the cells had lost the plasmid after 200 generations. The presence of the Lcn972 gene cluster under the control of the Phyb promoter slightly delayed segregation but it was finally lost after 167 generations (Figure 2A).The behavior of pOrf4 was radically different. Plasmid loss occurred quickly and after 50 generations only 20% of the isolated colonies were Em-resistant and Lcn972-producers (Figure 2B). Surprisingly, the percentage of Em-resistant colonies increased thereafter, and a supposedly homogenous Em-resistant population was recovered after 150 generations in which, all the tested colonies were positive in the bacteriocin activity test. This particular behavior was reproducible and repeating the experiment with another independent clone gave similar results (Figure 2B).
The deletion of the 705 bp downstream of the 5’ cloning site of pOrf4 to make pDorf4 largely enhanced plasmid stability to such extent that plasmid segregation was not longer observed (Figure 2B). To discard any fortuitous mutations and confirm that the 3.5 kbp DNA insert of pDorf4 could indeed stabilize pIL252, this DNA fragment was amplified by PCR, using as template pDorf4 and primers SPCf and SPCr (Table 2) and cloned in pIL252. Transformants were easily obtained and the newly constructed pDorf4 plasmid was as stable as pDorf4 created after deleting the Eco RI-Eco RV 705 bp-fragment from pOrf4.
These results support post-segregational killing as the most likely mechanism behind plasmid stabilization by the Lcn972 gene cluster because those recombinant plasmids producing high Lcn972 levels such as pLDH and pDorf4 (800–400 AU/mL) were kept in the population, while pHYB (200 AU/mL) was quickly lost. Post-segregational killing by bacteriocin-encoding plasmids in Gram positives has been demonstrated in pLgLA39, a plasmid encoding the circular bacteriocin gassericin A in Lactobacillus gasseri LA39. Deletion of the gassericin A structural gene in gassericin A-expressing plasmids significantly reduced plasmid stability .
The Lcn972 gene cluster stabilizes mCherry-expressing vectors
Further confirmation of the contribution of the Lcn972 gene cluster to plasmid maintenance was obtained by evaluating the loss of the expression vector pTLR1 in the absence of antibiotic selection. pTLR1 is a shuttle vector in which the mrfp gene, encoding the red fluorescent protein mCherry, is under the control of the constitutive Px promoter and it also carries the erythromycin resistance gene erm. This plasmid was chosen because the synthesis of mCherry could be easily assessed as plasmid-bearing colonies develop a pale pink colour on GM17 plates due to the functional expression of mCherry (Figure 3A). Moreover, fluorescent proteins are becoming the reporter of choice for in vivo gene expression studies, for example, during bacterial infection or gut colonization, where antibiotics cannot be present .The 3.5 kbp Lcn972 gene cluster was cloned in pTRL1 to create pTRL1_Lcn972. Production of Lcn972 was confirmed by the direct antagonism test (data not shown) and the stability of both plasmids was assessed (Figure 3B). Similar to the reference plasmid pIL252, pTRL1 was lost after 150 generations. On the contrary, pTRL1_Lcn972 was stable and maintained after 250 generations, validating the use of Lcn972 gene cluster to stabilize expression plasmids without compromising the synthesis of reporter proteins.
Insertion sequences are involved in the integration of pOrf4 into the chromosome
To explain the particular behavior of the plasmid pOrf4 in L. lactis NZ9000, three independent colonies (L. lactis 200 g-a, −b and -c) were selected once the population was stable. L. lactis 200 g-a was further sub-cultivated for another 200 generations and remained resistant to Em and produced Lcn972. One colony, L. lactis 400 g, i.e. L. lactis pOrf4 after 400 generations, was randomly selected and used in subsequent experiments.
Plasmid DNA could not be isolated from any of the L. lactis 200 g or L. lactis 400 g cultures grown on GM17Em, suggesting that the plasmid might have been integrated into the chromosome. A set of PCRs with primers annealing on the plasmid was designed to determine the fragments of pOrf4 that were involved in rearrangements with the chromosome (Figure 4A). It was determined that recombination had taken place within the intergenic region between repF and repD in L. lactis 200 g, and within the coding region of repE in L. lactis 400 g (Figure 4A). Moreover, direct sequencing on the chromosome with primers annealing on the plasmid and pointing towards both ends of the integration site revealed the presence of the insertion sequence IS981 at either side of the integrated plasmid pOrf4 in L. lactis 200 g and of IS1216 in L. lactis 400 g (Figure 4B).
The intrinsic instability of the plasmid pOrf4 must be due to the presence of the DNA sequence from the stop codon of repG to the internal Eco RV site in orf4. This region is absent in pDorf4 which is stably maintained as a plasmid. This particular DNA region is also present in the L. lactis plasmid pLP712 (98.7% identity in BlastN searches at NCBI) and it has been described as a hotspot for DNA rearrangements through the activity of insertion sequence elements as several deletion derivatives of pLP712 occur at this site . The presence of insertion sequences flanking the integrated pOrf4 plasmid also supports the contribution of these mobile elements that led to the integration of the pOrf4 plasmid.
Bacteriocin production by the pOrf4 integrants L. lactis 200 g and L. lactis 400 g was 200 AU/mL (data not shown). The bacteriocin titers are lower than those provided by the plasmid pOrf4 (Table 1), and may be explained by a reduced gene dosage as a consequence of integration. Still, the levels of Lcn972 were high enough to displace susceptible cells, further supporting the strong selection pressure exerted by this bacteriocin.
Selection of transformed lactococcal cells with Lcn972-recombinant plasmids after electroporation
Genes involved in resistance and immunity to bacteriocins from Gram positive bacteria have been claimed to facilitate selection of recombinant plasmids using the cognate bacteriocin as a selecting agent instead of antibiotics [13–15, 33]. Lcn972 was also useful to select pBL1-bearing L. lactis cells after electroporation with the plasmid content of the wild-type producer L. lactis IPLA972 . However, Lcn972 is a thermosensitive bacteriocin which makes its use as a selecting agent not very accurate as it might be inactivated during the preparation of selecting plates. Nevertheless, in view of the strong selective pressure that Lcn972 seems to apply on L. lactis, we checked if lactococcal cells that acquired plasmids bearing the Lcn972 cluster could compete against plasmid-free cells right after electroporation so that antibiotics, and consequently antibiotic resistance markers, would not be further required to select positive transformants. To test it, L. lactis NZ9000 was transformed with pDorf4 and after 90 min of incubation ten-fold dilutions were plated on GM17 with and without Em. After transformation, 0.01% of the cells was resistant to erythromycin, and regarded as true transformants carrying the plasmid (Figure 5). The transformation mix was subsequently sub-cultured in GM17 broth and transferred every 7–8 generations to fresh broth. Appropriate dilutions were also plated on GM17 and GM17Em to estimate the fraction of the population that still retained the plasmid. As shown in Figure 5, while there were still 4.3 log cfu/mL of Em-resistant counts after 24 generations, they were under the detection limit (<1 log cfu/mL) after 58 generations. Therefore, higher numbers of transformed cells, i.e. more Lcn972 producing cells, seems to be required in order to produce enough Lcn972 and displace plasmid-free cells in the absence of antibiotic selection.
The strong selective pressure exerted by bacteriocins can be exploited to enhance the segregational stability of recombinant plasmids when combined with their cognate immunity system, as shown in this work with the bacteriocin Lcn972. Once the Lcn972 recombinant plasmid is inside the cells, it is maintained without any obvious deleterious consequences for the cells and antibiotic pressure is no longer needed, providing a useful tool for the development of safer and more sustainable biotechnological applications of L. lactis.
Bacterial strains and growth conditions
Lactococcus lactis NZ9000  was used as host for cloning and L. lactis MG1614  was used as the Lcn972 susceptible strain. Lactococci were grown statically in M17 broth (Oxoid, Basingstoke, United Kingdom) supplemented with 0.5% (v/v) glucose (GM17) at 30°C. When needed, erythromycin was added at 5 μg/mL (GM17Em). Growth curves were started by inoculating pre-warmed GM17 with overnight cultures at an optical density at 600 nm (OD600) of 0.05. Growth rates (μ) were calculated from at least two independent cultures by linear regression of ln (OD600) versus time in the exponential phase and the generation time (g) as ln (2)/μ.
Lcn972 susceptibility tests
Screening of transformants for bacteriocin production was done by a direct antagonism test. Isolated colonies were stabbed on GM17 (1.2% agar) plates previously inoculated with 105cfu/mL of L. lactis MG1614 and the presence of inhibition halos was recorded after overnight incubation at 30°C. Bacteriocin activity in supernatants was quantified by the agar diffusion test using 20 μL of twofold dilutions placed in wells made on L. lactis MG1614 indicator plates. Arbitrary units (AU) were defined as the inverse of the last dilution that gave a clear halo and expressed by mL. The minimal inhibitory concentration (MIC) of Lcn972 for recombinant L. lactis was determined by the broth microdilution method as described before .
Plasmid pBL1  was used as the source of the Lcn972 gene cluster and plasmids pIL252  and pTLR1  were used as cloning vectors. An overview of the cloned inserts is shown in Figure 1. Restriction enzymes were purchased from Takara (Otsu, Japan) and used as recommended. Plasmids from lactococcal cultures were purified with High Pure Plasmid Isolation kit (Roche, Mannheim, Germany) and DNA from agarose gels was recovered using the Illustra GFX PCR DNA and Gel Band Purification kit (GE Healthcare, Buckinghamshire, United Kingdom). Transformation of L. lactis NZ9000 was carried out as described by Holo and Nes . To construct pLDH, the lactate dehydrogenase promoter (Pldh) was excised as a 289-bp Bam HI fragment from pRV85  and used to replace the 324 bp Bgl II-Bam HI nisin promoter in pBL54 where the promoterless Lcn972 gene cluster had been previously cloned (IPLA-CSIC, laboratory collection). From the resulting plasmid, the whole Lcn972 gene cluster fused to Pldh (3.6 kbp) was excised by digestion with Afe I and Sma I and ligated to pIL252 previously digested with Sma I, creating plasmid pLDH. The plasmid pHYB was constructed by replacing the 300 bp Eco RI carrying the promoter Pldh of pLDH by the 194 bp Eco RI fragment from pBL57 containing the hybrid promoter Phyb. pOrf4 was constructed by digesting pLDH with Eco RI and Dra III (internal to lcn972) to remove Pldh and the 5’end of lcn972 and subcloning of a Eco RI and Dra III digested amplicon (1.5 kbp) generated with primers orf4F and orf4R (Table 2) and pBL1 as template. PCR amplification was performed at 55°C melting temperature with the proofreading Phusion high fidelity polymerase (Fisher Scientific, Spain) as indicated by the manufacturer. orf4 in pOrf4 was partially deleted to yield pDorf4. To this end, pOrf4 was digested by Eco RI-Eco RV to delete a 705 bp fragment covering the 5’ end of the gene. Cohesive ends were filled with the DNA polymerase I Klenow fragment (Takara, Otsu, Japan) and blunt-end ligated. Plasmid pTLR1 based in the pAK80 vector and carrying the Px-mrfp fusion, which encodes constitutive expression of the fluorescent mCherry protein  was used to construct the expression shuttle plasmid pTRL1_Lcn972 (Figure 1). To this end, a PCR reaction using pDorf4 as template and the primers SPCf and SPCr flanking the Lcn972 gene cluster (Table 2) was performed. The 3.5 kbp PCR product was digested by Eco RV and Sma I and cloned upstream of mrfp into the Klenow-blunted Xho I-digested pTRL1 plasmid. All the recombinant plasmids were checked by DNA sequencing (Macrogen, Korea).
Segregational plasmid stability
L. lactis NZ9000 carrying each of the recombinant plasmids were sequentially inoculated in GM17 broth for 200 generations. Samples were taken and ten-fold dilutions were plated on GM17 agar plates to isolate individual colonies. Up to 168 colonies were checked at time intervals for resistance to erythromycin by replica-plating onto GM17Em plates and for Lcn972 production onto GM17 plates (1.2% agar) inoculated with L. lactis MG1614. Plates were incubated overnight at 30°C to score for growth in the presence of the antibiotic and for the development of inhibition halos, respectively. Stability of L. lactis NZ9000/pTRL1_Lcn972 was followed by screening for pink/white colonies after plating on GM17 agar to discriminate between mCherry expressing and non-expressing cells.
Mapping of pOrf4 integrants
To determine the plasmid region involved in the integration of pOrf4 into the chromosome, primers orf4-F/lcn2, ery5/orf4-R, eryrepF-F/repE-R, and repE-F/repE2-R listed in Table 2 were designed and combined in PCR reactions performed with PuRe Taq Ready-to-Go PCR beads (GE Healthcare, Buckinghamshire, United Kingdom), using as template the plasmid pOrf4, total DNA of L. lactis 200 g, and total DNA of L. lactis 400 g. Direct sequencing of the chromosome was carried out by Secugen (Madrid, Spain) using 2.5 - 3 μg of total DNA of L. lactis 200 g and of L. lactis 400 g and the primers 201 g-F/201 g-R and 402 g-F/402 g-R, respectively.
Gaspar P, Carvalho AL, Vinga S, Santos H, Neves AR: From physiology to systems metabolic engineering for the production of biochemicals by lactic acid bacteria. Biotechnol Adv. 2013, 31: 764-788. 10.1016/j.biotechadv.2013.03.011.
Gaspar P, Neves AR, Gasson MJ, Shearman CA, Santos H: High yields of 2,3-butanediol and mannitol in Lactococcus lactis through engineering of NAD (+) cofactor recycling. Appl Environ Microbiol. 2011, 77: 6826-6835. 10.1128/AEM.05544-11.
LeBlanc JG, Sybesma W, Starrenburg M, Sesma F, de Vos WM, de Giori GS, Hugenholtz J: Supplementation with engineered Lactococcus lactis improves the folate status in deficient rats. Nutrition. 2010, 26: 835-841. 10.1016/j.nut.2009.06.023.
Bermúdez-Humarán LG, Kharrat P, Chatel JM, Langella P: Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact. 2011, 10 (Suppl 1): S4-10.1186/1475-2859-10-S1-S4.
Peterbauer C, Maischberger T, Haltrich D: Food-grade gene expression in lactic acid bacteria. Biotechnol J. 2011, 6: 1147-1161. 10.1002/biot.201100034.
de Vos WM: Systems solutions by lactic acid bacteria: from paradigms to practice. Microb Cell Fact. 2011, 10 (Suppl 1): S2-10.1186/1475-2859-10-S1-S2.
Oliveira PH, Mairhofer J: Marker-free plasmids for biotechnological applications - implications and perspectives. Trends Biotechnol. 2013, 31: 539-547. 10.1016/j.tibtech.2013.06.001.
Sevillano L, Díaz M, Santamaría RI: Stable expression plasmids for Streptomyces based on a toxin-antitoxin system. Microb Cell Fact. 2013, 12: 39-10.1186/1475-2859-12-39.
Platteeuw C, van Alen-Boerrigter I, van Schalkwijk S, de Vos WM: Food-grade cloning and expression system for Lactococcus lactis. Appl Environ Microbiol. 1996, 62: 1008-1013.
Sørensen KI, Larsen R, Kibenich A, Junge MP, Johansen E: A food-grade cloning system for industrial strains of Lactococcus lactis. Appl Environ Microbiol. 2000, 66: 1253-1258. 10.1128/AEM.66.4.1253-1258.2000.
Solem C, Defoor E, Jensen PR, Martinussen J: Plasmid pCS1966, a new selection/counterselection tool for lactic acid bacterium strain construction based on the oroP gene, encoding an orotate transporter from Lactococcus lactis. Appl Environ Microbiol. 2008, 74: 4772-4775. 10.1128/AEM.00134-08.
Lu W, Kong J, Kong W: Construction and application of a food-grade expression system for Lactococcus lactis. Mol Biotechnol. 2013, 54: 170-176. 10.1007/s12033-012-9558-z.
Takala TM, Saris PE: A food-grade cloning vector for lactic acid bacteria based on the nisin immunity gene nisI. Appl Microbiol Biotechnol. 2002, 59: 467-471. 10.1007/s00253-002-1034-4.
Mills S, Coffey A, O'Sullivan L, Stokes D, Hill C, Fitzgerald GF, Ross RP: Use of lacticin 481 to facilitate delivery of the bacteriophage resistance plasmid, pCBG104 to cheese starters. J Appl Microbiol. 2002, 92: 238-246. 10.1046/j.1365-2672.2002.01527.x.
Coakley M, Fitzgerald G, Ros RP: Application and evaluation of the phage resistance- and bacteriocin-encoding plasmid pMRC01 for the improvement of dairy starter cultures. Appl Environ Microbiol. 1997, 63: 1434-1440.
Martínez B, Rodríguez A, Suárez JE: Lactococcin 972, a bacteriocin that inhibits septum formation in lactococci. Microbiology. 2000, 146: 949-955.
Martínez B, Böttiger T, Schneider T, Rodríguez A, Sahl HG, Wiedemann I: Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II. Appl Environ Microbiol. 2008, 74: 4666-4670. 10.1128/AEM.00092-08.
Martínez B, Fernández M, Suárez JE, Rodríguez A: Synthesis of lactococcin 972, a bacteriocin produced by Lactococcus lactis IPLA 972, depends on the expression of a plasmid encoded bicistronic operon. Microbiology. 1999, 145: 3155-3161.
Sánchez C, de Hernández Rojas A, Martínez B, Arguelles ME, Suárez JE, Rodríguez A, Mayo B: Nucleotide sequence and analysis of pBL1, a bacteriocin-producing plasmid from Lactococcus lactis IPLA 972. Plasmid. 2000, 44: 239-249. 10.1006/plas.2000.1482.
Simon D, Chopin A: Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis. Biochimie. 1988, 70: 559-566. 10.1016/0300-9084(88)90093-4.
Roces C, Campelo AB, Veiga P, Pinto JPC, Rodríguez A, Martínez B: Contribution of the CesR-regulated genes llmg0169 and llmg2164-2163 to Lactococcus lactis fitness. Int J Food Microbiol. 2009, 133: 279-285. 10.1016/j.ijfoodmicro.2009.06.002.
Gory L, Montel MC, Zagorec M: Use of green fluorescent protein to monitor Lactobacillus sakei in fermented meat products. FEMS Microbiol Lett. 2001, 194: 127-133. 10.1111/j.1574-6968.2001.tb09457.x.
Roces C, Pérez V, Campelo AB, Blanco D, Kok J, Kuipers OP, Rodríguez A, Martínez B: The putative lactococcal extracytoplasmic function anti-sigma factor llmg2447 determines resistance to the cell wall-active bacteriocin lcn972. Antimicrob Agents Chemother. 2012, 56: 5520-5527. 10.1128/AAC.01206-12.
Stein T, Heinzmann S, Solovieva I, Entian KD: Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis. J Biol Chem. 2003, 278: 89-94.
Draper LA, Grainger K, Deegan LH, Cotter PD, Hill C, Ross RP: Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol Microbiol. 2009, 71: 1043-1054. 10.1111/j.1365-2958.2008.06590.x.
Maqueda M, Sánchez-Hidalgo M, Fernández M, Montalbán-López M, Valdivia E, Martínez-Bueno M: Genetic features of circular bacteriocins produced by Gram-positive bacteria. FEMS Microbiol Rev. 2008, 32: 2-22. 10.1111/j.1574-6976.2007.00087.x.
Guo T, Hu S, Kong J: Functional analysis and randomization of the nisin-inducible promoter for tuning gene expression in Lactococcus lactis. Curr Microbiol. 2013, 66: 548-554. 10.1007/s00284-013-0312-y.
Jensen PR, Hammer K: Artificial promoters for metabolic optimization. Biotechnol Bioeng. 1998, 58: 191-195. 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G.
Ito Y, Kawai Y, Arakawa K, Honme Y, Sasaki T, Saito T: Conjugative plasmid from Lactobacillus gasseri LA39 that carries genes for production of and immunity to the circular bacteriocin gassericin A. Appl Environ Microbiol. 2009, 75: 6340-6351. 10.1128/AEM.00195-09.
García-Cayuela T, de Cadinanos LP, Mohedano ML, de Palencia PF, Boden D, Wells J, Peláez C, López P, Requena T: Fluorescent protein vectors for promoter analysis in lactic acid bacteria and Escherichia coli. Appl Microbiol Biotechnol. 2012, 96: 171-181. 10.1007/s00253-012-4087-z.
Bumann D, Valdivia RH: Identification of host-induced pathogen genes by differential fluorescence induction reporter systems. Nat Protoc. 2007, 2: 770-777. 10.1038/nprot.2007.78.
Wegmann U, Overweg K, Jeanson S, Gasson M, Shearman C: Molecular characterization and structural instability of the industrially important composite metabolic plasmid pLP712. Microbiology. 2012, 158: 2936-2945. 10.1099/mic.0.062554-0.
Li R, Takala TM, Qiao M, Xu H, Saris PE: Nisin-selectable food-grade secretion vector for Lactococcus lactis. Biotechnol Lett. 2010, 33: 797-803.
de Ruyter PG, Kuipers OP, de Vos WM: Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol. 1996, 62: 3662-3667.
Gasson MJ: Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol. 1983, 154: 1-9.
Holo H, Nes IF: Transformation of Lactococcus by electroporation. Methods Mol Biol. 1995, 47: 195-199.
This work has been funded by grant BIO2010-17414 (Ministerio de Ciencia e Innovación, Spain). Work of PL and MLM was supported by grant AGL2012-40084-C03-01 (Ministerio de Economía y Competitividad, Spain). We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI). C.R. was a recipient of a predoctoral JAE-CSIC fellowship. We thank Monique Zagorec (INRA, France) for sharing the plasmid pRV85. We also thank Pilar García (IPLA-CSIC, Spain) for critical review of this manuscript and Victor Ladero (IPLA-CSIC, Spain) for helpful discussions.
The authors declare that they do not have competing interests.
ABC and CR carried out the experiments. MLM and PL contributed to the pTRL1 experiments. BM conceived the work and together with AR designed, supervised, and wrote the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Campelo, A.B., Roces, C., Mohedano, M.L. et al. A bacteriocin gene cluster able to enhance plasmid maintenance in Lactococcus lactis . Microb Cell Fact 13, 77 (2014). https://doi.org/10.1186/1475-2859-13-77
- Plasmid segregation
- Post-segregational killing
- Insertion sequences
- Lactococcus lactis